Biocon surged over 3% to a high of Rs. 470 after the company's subsidiary - Syngene International filed a Draft Red Herring Prospectus with the Securities and Exchange Board of India for an IPO.
The stock, however, ended down nearly a percent at Rs. 452 at the BSE counter.
The stock has hit a high of RS. 470 and a low of Rs. 449.